•
Dec 31, 2018

REGENXBIO Q4 2018 Earnings Report

Total Revenue
$40.8M
Previous year: $2.04M
+1898.9%
EPS
$0.11
Previous year: -$0.51
-121.6%
Gross Profit
$37.9M
Previous year: -$11.7M
-422.9%
Cash and Equivalents
$75.6M
Previous year: $46.7M
+62.0%
Free Cash Flow
-$9.03M
Previous year: -$15.9M
-43.3%
Total Assets
$544M
Previous year: $199M
+173.7%

REGENXBIO

REGENXBIO